Jan 08, 2018 12:31 pm UTC| Business
- Dr. Ludwig brings over 20 years of leadership and management expertise from Eli Lilly and Company and Imclone Systems, Inc. in oncology antibody therapeutics discovery and development where he supported the development...
Jan 08, 2018 12:30 pm UTC| Business
TORONTO, Jan. 08, 2018 -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time MR imaging combined...
Valeritas Reports Preliminary Full Year and Fourth Quarter 2017 Revenue Results
Jan 08, 2018 12:30 pm UTC| Business
BRIDGEWATER, N.J., Jan. 08, 2018 -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable,...
Jan 08, 2018 12:30 pm UTC| Business
NEWTOWN, Pa., Jan. 08, 2018 -- Helius Medical Technologies, Inc. (TSX:HSM) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, announced today that...
McDermott Updates Investors Regarding Proposed Combination
Jan 08, 2018 12:30 pm UTC| Business
HOUSTON, Jan. 08, 2018 -- McDermott International, Inc. (NYSE:MDR) today provided an updated investor presentation regarding its proposed combination with CBI (NYSE:CBI) which was announced on December 18, 2017. The...
TG Therapeutics, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
Jan 08, 2018 12:30 pm UTC| Business
NEW YORK, Jan. 08, 2018 -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will present at the 36th Annual J.P. Morgan Healthcare...
Jan 08, 2018 12:30 pm UTC| Business
Data show that 95% of patients achieved clinical benefit after a single administration of ZILRETTATo date, 90% of eligible patients received a second administration between Weeks 12 and 24 BURLINGTON, Mass., Jan. 08,...